Hongsheng Zhou
- Hematology top 1%
- Acute Myeloid Leukemia Research 27
- Chronic Myeloid Leukemia Treatments 27
- Hematopoietic Stem Cell Transplantation 18
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 10
- Oncology top 10%
- CAR-T cell therapy research 17
- Immunology top 10%
-
- Acute Lymphoblastic Leukemia research 35
-
- Histone Deacetylase Inhibitors Research 10
-
- Cytomegalovirus and herpesvirus research 9
- Cited by
- HematologyGeneticsOncology
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hongsheng Zhou
123 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 106
- Hematology 751
- Genetics 397
- Oncology 314
- Immunology 219
- Cancer Research 150
Countries citing papers authored by Hongsheng Zhou
This map shows the geographic impact of Hongsheng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongsheng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongsheng Zhou more than expected).
Fields of papers citing papers by Hongsheng Zhou
This network shows the impact of papers produced by Hongsheng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongsheng Zhou. The network helps show where Hongsheng Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongsheng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 16 | |
| 15 | 2020 | 8 | |
| 16 | 2020 | 18 | |
| 17 | 2018 | 67 | |
| 18 | 2017 | 1 | |
| 19 | 2016 | 19 | |
| 20 | 2012 | 23 |
About Hongsheng Zhou
Hongsheng Zhou is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 127 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (35 papers), Acute Myeloid Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (27 papers), Hematopoietic Stem Cell Transplantation (18 papers), CAR-T cell therapy research (17 papers), Chronic Lymphocytic Leukemia Research (10 papers), Histone Deacetylase Inhibitors Research (10 papers) and Cytomegalovirus and herpesvirus research (9 papers). The work is most often cited by research in Hematology (751 citations), Genetics (397 citations) and Oncology (314 citations). Hongsheng Zhou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qifa Liu, Michael Andreeff, Fen Huang, Zhiping Fan, Jing Sun, Yu Zhang, Jörge E. Cortes, Po Yee Mak, Guopan Yu and Duncan H. Mak. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.